Peer-to-Peer Podcast
| Activity Title | HSDD Peer-to-Peer Podcast #6 |
| Topic | Describe nonpharmacological interventions and alternative therapies for HSDD |
| Target Audience | Obstetricians/gynecologists, family physicians, internal medicine physicians, nurse practitioners, physician assistants, and other health care providers managing patients with HSDD and other female sexual dysfunctions |
| Accreditation Type | CME |
| Release Date | October 2010 |
| Expiration Date | October 31, 2011 |
| Estimated Time to Complete Activity | 15 minutes |
LEARNING OBJECTIVES
Upon completion of the activity, participants should be able to:
- Review the investigational pharmacological and nonpharmacological management options for HSDD
FACULTY
Anita H. Clayton, MD
Professor of Psychiatry and Neurobehavioral Sciences
Medical Director
Outpatient Psychiatry Clinic and
Center for Psychiatric Clinical Research
University of Virginia School of Medicine
Charlottesville, Virginia
Ana Núñez, MD
Associate Professor of Internal Medicine
Director, Women's Health Education Program
Drexel University College of Medicine
Philadelphia, Pennsylvania
James A. Simon, MD, CCD, NCMP, FACOG
Clinical Professor of Obstetrics and Gynecology
George Washington University
President and Medical Director
Women's Health and Research Consultants
Washington, DC
METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT
- There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives and CME/CE information.
- Complete the CME/CE activity
- Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
- Your CME/CE certificate will be emailed to you.
SPONSOR
This activity is sponsored by the University of Nebraska Medical Center, Center for Continuing Education and The France Foundation.
 |
 |
TARGET AUDIENCE
This activity is intended for obstetricians/gynecologists, family physicians, internal medicine physicians, nurse practitioners, physician assistants, and other health care providers managing patients with hypoactive sexual desire disorder (HSDD).
STATEMENT OF NEED
Despite the high frequency and personal impact of HSDD, women are hesitant to initiate discussions with their health care professionals about their sexual health or potential concerns. There are many reasons that have been suggested for this hesitancy, such as being fearful about time constraints, lack of effective treatments, and both patient and health care professional embarrassment. Additionally, surveys have discovered that health care professionals rarely initiate communication with their female patients regarding this topic. Furthermore, surveys have found that health care professionals in both primary care and specialty care of women are not well trained in this area, do not feel they are skilled on how to effectively communicate on this topic, and are not comfortable on how to diagnosis and manage sexual concerns with their female patients. This is further complicated by the limited availability of proven treatment options for HSDD.
ACCREDITATION STATEMENT
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION
Physicians
The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
RESOLUTION OF CONFLICTS OF INTEREST
In accordance with the ACCME Standards for Commercial Support of CME, The University of Nebraska Medical Center, Center for Continuing Medical Education and The France Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.
DISCLOSURE
It is the policy of The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, and staff involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation have identified and resolved any and all conflicts of interest prior to the release of this activity.
Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, or other members at the University of Nebraska Medical Center, Center for Continuing Medical Education who control content have no relevant financial relationships to disclose.
The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.
Faculty Disclosure
The following faculty has indicated they have relationships with industry to disclose relative to the content of this CME activity:
- Anita H. Clayton, MD, has received grant and research support from BioSante Pharmaceuticals and Boehringer Ingelheim. She has served as a consultant for and received honoraria from Boehringer Ingelheim. Dr. Clayton has received other financial or material support from Random House, Guilford Publications, and the Changes in Sexual Functioning Questionnaire.
- Ana Núñez, MD, has served as a consultant for the National Heart, Lung, and Blood Institute and the Institute for Women's Health. She has received honoraria from Merck.
- James A. Simon, MD, CCD, NCMP, FACOG, has served as a consultant for Allergan, Alliance for Better Bone Health, Amgen, Ascend Therapeutics, Azur Pharma, BioSante Pharmaceuticals, Boehringer Ingelheim, Concert Pharmaceuticals, Corcept Therapeutics, Depomed, Fabre-Kramer Pharmaceutical, GlaxoSmithKline, Graceway Pharmaceuticals, KV Pharmaceutical, Lipocine, Meditrina Pharmaceuticals, Merck, Merrion Pharmaceuticals, Nanma Manufacturing Company LTD, NDA Partners, Novo Nordisk, Novogyne Pharmaceuticals, Pear Tree Pharmaceuticals, QuatRx Pharmaceuticals, Roche, Schering Plough, Sciele Pharma, Solvay, Teva Neuroscience, Inc, Ther-Rx Corporation, Trinity Pharma Solutions, TriPharma, LLC, Warner Chilcott, and Wyeth. He has received grant and research support from BioSante Pharmaceuticals, Boehringer Ingelheim, Femme Pharma Inc, GlaxoSmithKline, Nanma Manufacturing Company LTD, Novartis, Procter & Gamble, QuatRx Pharmaceuticals, Teva Neuroscience, Trinity Pharma Solutions, and TriPharma, LLC. Dr. Simon has served on speakers bureaus for Amgen, Ascend Therapeutics, Bayer, Boehringer Ingelheim, GlaxoSmithKline, KV Pharmaceutical, Merck, Novartis, Novogyne Pharmaceuticals, Shionogi Pharma, Teva Neuroscience, Ther-Rx Corporation, Warner Chilcott, and Wyeth.
UNAPPROVED USE DISCLOSURE
The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation require CME faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an educational grant from Boehringer Ingelheim.
DISCLAIMER
The University of Nebraska Medical Center, Center for Continuing Education and The France Foundation present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The University of Nebraska Medical Center, Center for Continuing Education, The France Foundation, and Boehringer Ingelheim assume no liability for the information herein.
COPYRIGHT INFORMATION
Copyright © 2010 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:
- The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
- Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission.
PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.
The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.
Additional information regarding The France Foundation's Privacy Policy can be viewed at http://www.francefoundation.com/privacy.
CONTACT INFORMATION
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.
To apply for credit, Click here >>
